Technical Analysis for ENZ - Enzo Biochem, Inc.

Grade Last Price % Change Price Change
D 1.13 -1.74% -0.02
ENZ closed down 1.74 percent on Friday, November 1, 2024, on 77 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
Earnings due: Nov 4
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Flat Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
Gapped Down Weakness 0.00%
200 DMA Resistance Bearish -1.74%
20 DMA Support Bullish -1.74%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 19 hours ago
Gap Up Closed about 23 hours ago
Gap Up Partially Closed about 23 hours ago
Reversed from Up about 23 hours ago
Gap Down Partially Closed about 23 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Enzo Biochem, Inc. Description

Enzo Biochem, Inc., an integrated life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Clinical Labs, Life Sciences, and Therapeutics. The Clinical Labs segment offers routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. This segment operates a full-service clinical laboratory, a network of approximately 30 patient service centers, a laboratory, and a full-service phlebotomy and in-house logistics department. The Life Sciences segment manufactures, develops, and markets products and tools to life sciences, drug development, and clinical research customers. It provides proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which offer tools for target identification/validation, high content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis to life science researchers. This segment provides its products to scientific experts primarily in the field of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Therapeutics segment researches and develops therapeutic drug candidates in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. The company sells its products through its direct sales force; and a network of distributors worldwide. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Cancer Life Sciences Biology Acid Diabetes Autoimmune Disease Antibodies Molecular Biology Gastrointestinal Drug Development Clinical Research Cardiovascular Disease Obesity Neurological Disorders Ophthalmic Genetic Engineering Lab Testing Metabolic Disease Gene Expression Peptides Urological Disorders Dyes Medical Laboratory Search Products Biochemistry Research Products Endocrine Disorders Medical Diagnosis Diagnostic And Research Products

Is ENZ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.5
52 Week Low 0.9901
Average Volume 59,535
200-Day Moving Average 1.17
50-Day Moving Average 1.13
20-Day Moving Average 1.14
10-Day Moving Average 1.14
Average True Range 0.04
RSI (14) 47.92
ADX 21.63
+DI 18.41
-DI 12.41
Chandelier Exit (Long, 3 ATRs) 1.08
Chandelier Exit (Short, 3 ATRs) 1.22
Upper Bollinger Bands 1.16
Lower Bollinger Band 1.11
Percent B (%b) 0.34
BandWidth 3.99
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram -0.0007
Fundamentals Value
Market Cap 57.05 Million
Num Shares 50.5 Million
EPS -0.51
Price-to-Earnings (P/E) Ratio -2.22
Price-to-Sales 2.15
Price-to-Book 0.92
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.18
Resistance 3 (R3) 1.18 1.17 1.17
Resistance 2 (R2) 1.17 1.16 1.17 1.16
Resistance 1 (R1) 1.15 1.15 1.15 1.15 1.16
Pivot Point 1.14 1.14 1.14 1.14 1.14
Support 1 (S1) 1.12 1.13 1.12 1.12 1.10
Support 2 (S2) 1.11 1.12 1.11 1.10
Support 3 (S3) 1.09 1.11 1.09
Support 4 (S4) 1.09